BSE
MARKET ANALYSIS NEWS CORPORATE INFORMATION CORPORATE ACTIONS OTHER MARKETS
Your Result on : Company News Details
Supriya Lifescience Ltd Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
543434
ISIN Demat
INE07RO01027
Book Value (Rs)
148.8189477
NSE Symbol
SUPRIYA
Divident Yield %
0.11
Market Cap
(Rs In Cr.)
7,444
P/E (TTM)
35.53
EPS (TTM)
26.03
Face Value
(Rs)
2
Back
Supriya Lifescience standalone net profit rises 47.34% in the March 2026 quarter
28-May-26   Hrs IST

Net profit of Supriya Lifescience rose 47.34% to Rs 74.23 crore in the quarter ended March 2026 as against Rs 50.38 crore during the previous quarter ended March 2025. Sales rose 50.20% to Rs 276.53 crore in the quarter ended March 2026 as against Rs 184.11 crore during the previous quarter ended March 2025.

For the full year,net profit rose 11.26% to Rs 209.12 crore in the year ended March 2026 as against Rs 187.96 crore during the previous year ended March 2025. Sales rose 18.86% to Rs 827.88 crore in the year ended March 2026 as against Rs 696.49 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales276.53184.11 50 827.88696.49 19
OPM %35.3036.71 -35.5237.44 -
PBDT100.6370.14 43 303.65268.93 13
PBT92.1364.06 44 275.24248.49 11
NP74.2350.38 47 209.12187.96 11

Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, Developed and Maintained by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)